Literature DB >> 23927442

Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control study.

Marc Blondon1, Kerri L Wiggins, Astrid Van Hylckama Vlieg, Barbara McKnight, Bruce M Psaty, Kenneth M Rice, Susan R Heckbert, Nicholas L Smith.   

Abstract

Entities:  

Keywords:  hormone therapy; interaction; menopause; smoking; venous thrombosis

Mesh：

Substances：

Year:  2013        PMID： 23927442      PMCID： PMC4363922          DOI： 10.1111/bjh.12508

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  Multiple imputation: a primer.

Authors:  J L Schafer
Journal:  Stat Methods Med Res       Date:  1999-03       Impact factor: 3.021

2.  Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study.

Authors:  Sigrid K Brækkan; Erin M Hald; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; Frits R Rosendaal; John-Bjarne Hansen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

3.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors:  Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

4.  Venous thrombosis and conjugated equine estrogen in women without a uterus.

Authors:  J David Curb; Ross L Prentice; Paul F Bray; Robert D Langer; Linda Van Horn; Vanessa M Barnabei; Michael J Bloch; Michele G Cyr; Margery Gass; Lisa Lepine; Rebecca J Rodabough; Stephen Sidney; Gabriel I Uwaifo; Frits R Rosendaal
Journal:  Arch Intern Med       Date:  2006-04-10

5.  Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use.

Authors:  Elisabeth R Pomp; Frits R Rosendaal; Carine J M Doggen
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

6.  Estrogen plus progestin and risk of venous thrombosis.

Authors:  Mary Cushman; Lewis H Kuller; Ross Prentice; Rebecca J Rodabough; Bruce M Psaty; Randall S Stafford; Steven Sidney; Frits R Rosendaal
Journal:  JAMA       Date:  2004-10-06       Impact factor: 56.272

7.  Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

Authors:  Nicholas L Smith; Susan R Heckbert; Rozenn N Lemaitre; Alex P Reiner; Thomas Lumley; Noel S Weiss; Eric B Larson; Frits R Rosendaal; Bruce M Psaty
Journal:  JAMA       Date:  2004-10-06       Impact factor: 56.272

8.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

9.  The association of smoking with venous thrombosis in women. A population-based, case-control study.

Authors:  M Blondon; K L Wiggins; B McKnight; B M Psaty; K M Rice; S R Heckbert; N L Smith
Journal:  Thromb Haemost       Date:  2013-03-07       Impact factor: 5.249

10.  Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.

Authors:  S Sweetland; V Beral; A Balkwill; B Liu; V S Benson; M Canonico; J Green; G K Reeves
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824
  10 in total
  1 in total

1.  Serum uric acid is associated with increased risk of idiopathic venous thromboembolism in high HDL-C population: A case-control study.

Authors:  Miao Yu; Ken Ling; Yunfei Teng; Qin Li; Fei Mei; Yiqing Li; Chenxi Ouyang
Journal:  Exp Ther Med       Date:  2016-04-05       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.